Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Rona Therapeutics logo — Empower Great People To Do Great Things

Rona Therapeutics

Empower Great People To Do Great Things

Founded 2021 China Shanghai, China 10 employees Series A Total: $68.00M Biotechnology, Health Care +1

General Information

Company Name Rona Therapeutics
Founded Year 2021
Location China Shanghai, China +1
Employees 10
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Series A
Social

Get notified when Rona Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Rona Therapeutics

Rona Therapeutics is a biotechnology startup, founded in 2021 and based in China. The company's mission is to develop modular and programmable RNA medicines for global patients. Rona Therapeutics boasts a team led by an industry veteran and renowned scientific advisors with expertise in RNA therapeutics. The company recently secured a significant $33.00M Series A investment on 07 April 2022 from a notable group of investors including Lilly Asia Ventures, Wu Capital, China Merchants Bank International, FC Capital, Fontus Capital, and Lanting Capital. Rona Therapeutics' innovative approach to RNA therapeutics positions it as a promising player in the evolving landscape of healthcare technology. The company's focus on RNA-based solutions has the potential to revolutionize treatment options and delivery mechanisms for patients worldwide.

Taxonomy: RNA therapeutics, modular RNA medicines, programmable RNA, scientific advisors, pharmaceuticals, drug discovery, biomedical research, innovation, precision medicine

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 5
Investor Investor Investor Investor
•••• •••• 		19 Jul 2024
Series A •••••• 5
Investor Investor Investor Investor
•••• •••• 		07 Apr 2022

Rona Therapeutics Alternatives & Competitors

Rona Therapeutics vs
AIRNA
AIRNA United States

The next generation of RNA editing therapeutics

Series B
84 employees
Biotechnology, Health Care
Rona Therapeutics vs
ReNAgade Therapeutics
ReNAgade Therapeutics United States

RNA Without Limits

Series A
24 employees
Biotechnology, Health and Wellness
Rona Therapeutics vs
Skyhawk Therapeutics
Skyhawk Therapeutics United States

We Use Small Molecules To Modify RNA Splicing

Series Unknown
81 employees
Biotechnology, Health and Wellness

FAQ About Rona Therapeutics

Empower Great People To Do Great Things
Rona Therapeutics was founded in 2021.
Rona Therapeutics is headquartered in Shanghai, China.
Rona Therapeutics operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Rona Therapeutics has approximately 10 employees.
Rona Therapeutics has completed 2 funding rounds, raising a total of $68.00M. The latest funding stage is Series A.
Top alternatives and competitors to Rona Therapeutics include AIRNA, ReNAgade Therapeutics, Skyhawk Therapeutics, Orna Therapeutics, VaxEquity Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Rona Therapeutics and AIRNA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Rona Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes